Wednesday, November 01, 2017 10:15 PM ET
VBI Vaccines (VBIV) sees Significant Insider buy Extending Trend of purchases over Last Quarter
An insider — Opko Health, Inc., 10% Owner — acquired 655,738 shares of VBI Vaccines having a market value of approximately $2,000,001 today, as disclosed in a form 4 document filed with the SEC. There have been 5 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been buys resulting in the acquisition of 6,523,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net purchases of 7,178,738 shares and have averaged 1,196,456 shares per transaction over this time period.
Insider buy/sell trading at VBI Vaccines is above the 184 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 209 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for VBI Vaccines insiders was also higher. Within the peer group there were 22,586,199 shares purchased and 51,313,333 shares sold with company insiders selling 137,450 shares on average.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in creating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.